News


IXICO webinar session;
Using MRI to assess safety, efficacy and eligibility of new Alzheimer's Disease therapies. This Webinar is now over. “We were overwhelmed with the turnout and level of participation”.Ciaran Cooper. VP Business Development.
A re-run of this session will be announced soon.
For more information  Click here

ISO 9001 Certified

Therapeutic Areas

IXICO works with customers in the pharmaceutical and biotechnology industries to deliver imaging solutions in pre-clinical studies and clinical trials.

  • IXICO is dedicated to enhancing the development pipeline
  • IXICO provides innovative imaging solutions
  • IXICO is committed to ensuring the best images are acquired

Our Offering

IXICO is an agile company that offers both standard and customised solutions in a number of therapeutic areas including Oncology, CNS and Musculoskeletal, across all the phases in the drug discovery and development pipeline. We also conduct and manage exploratory projects with our customers to assess the value of imaging in new or evolving therapeutic areas.

Experimental Studies

IXICO works with scientists in the pharmaceutical industry using experimental imaging facilities, who typically have unique image acquisition challenges. We work collaboratively to devise and implement solutions to maximise the value they can obtain from their image data and to save them from time-consuming and repetitive analysis tasks. This can significantly free up their time for designing and conducting high quality research.

Early Phase Clinical Trials

IXICO offers a complete site management and image analysis solution for early stage clinical trials using MRI , PET and CT imaging. IXICO is typically engaged by the trial sponsor to define the image acquisition protocol, write the acquisition manual, train the technologists at each site, handle image data logistics, perform endpoint specific quality control, and perform customised data analysis. We also work collaboratively with other partners where we perform a specific part of the trial management.

Late Phase Clinical Trials

IXICO offers a quality assured image analysis solution both independently and also in partnership with larger imaging CROs and academic CORE labs. IXICO also provides an image acquisition trouble-shooting service to assist trial sponsors or larger CROs in optimising the quality of all trial image data.

"Working with our customers, we can unlock imaging's potential to accelerate and reduce the costs of product development, and hence give more patients earlier access to effective and safe treatments."

Prof Derek Hill,
CEO, IXICO

New article

Expert Opinion on Investigational Drugs - by Derek Hill, CEO

The North American Alzheimer's Disease Neuroimaging Initiative, and similar activities in Europe, Japan, and Australia, are natural history studies that are providing new insights into the use of imaging end points in clinical trials. See the article here.